Loading
Safeguard Scientifics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SATTERFIELD THOMAS A JR, was filed 21 Aug 2023.
Safeguard Scientifics Inc: what insiders have been doing
Every trade that managers of Safeguard Scientifics Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Business Services sector. Safeguard Scientifics Inc has had no insider filing for more than a year; the last one goes back to 1 February 2024.
Looking back to 2006, when coverage begins, insiders filed 86 purchases and 13 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at ELIS and GL Events. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
554
Thresholds
n/a
Buy Volume
€4M
86 ops. · all time
Sell Volume
€961,697
13 ops. · all time
Since the insiders bought
- -27.5%Entry US$1.20 · Close at T+365 US$0.87
- +21.3%Entry US$6.10 · Close at T+365 US$7.40
- +22.5%Entry US$5.55 · Close at T+365 US$6.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 26,120 of 26,250 companies
5.1
score / 100
Value3
Quality7
FCF yld-40%
Earn yld-118%
EV/EBITDA·
ROE-36%
Gross mgn·
Net mgn-33%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2023FY ended December 2023 · cache
US$0.50
Analyst consensus
Income statement
RevenueUS$30M
EBITDA-US$5.4M-18% margin
Net income-US$9.8M0.0% margin
Valuation
P/Book0.4x
Beta-0.85
Balance sheet & cash
Market capUS$8.4M
Total debtUS$1.2M
Free Cash Flow-US$3.3M
Debt / Equity6%
Profitability & ownership
ROE-36.0%
ROA-11.7%
% institutions0.0%
Last declaration on 1 February 2024
Declarations554 total
38,087 shares@ US$0.7110.8% of flowCommon Stock, $0.10 par valueSEC:0000921895-24-000185:0
20,775 shares@ US$0.718.8% of flowCommon StockSEC:0001437749-24-002622:0
20,775 shares@ US$0.7114.9% of flowCommon StockSEC:0001437749-24-002626:0
22,506 shares@ US$0.7117.5% of flowCommon StockSEC:0001437749-24-002624:0
63,614 shares@ US$1.038.9% of flowCommon StockSEC:0001437749-23-034825:1
5,244 shares@ US$1.030.7% of flowCommon StockSEC:0001437749-23-034825:2
125,000 shares0Common StockSEC:0001437749-23-034825:0
5,318 shares@ US$0.99622.6% of flowCommon StockSEC:0001437749-23-032292:0
26,266 shares@ US$1.1112.0% of flowCommon Stock, $0.10 par valueSEC:0000921895-23-002349:0
14,327 shares@ US$1.119.8% of flowCommon StockSEC:0001437749-23-028335:0
15,521 shares@ US$1.1119.3% of flowCommon StockSEC:0001437749-23-028338:0
5,298 shares@ US$1.113.0% of flowCommon StockSEC:0001437749-23-028346:0
14,327 shares@ US$1.1116.5% of flowCommon StockSEC:0001437749-23-028341:0
5,298 shares@ US$1.1343.1% of flowCommon StockSEC:0001437749-23-026168:0
15,000 shares@ US$1.191.0% of flowCommon StockSEC:0001209191-23-046784:1
Canonical exit: 15 Nov 2023 (T+90)
124,196 shares@ US$1.188.6% of flowCommon StockSEC:0001209191-23-046784:2
117,000 shares@ US$1.178.0% of flowCommon StockSEC:0001209191-23-046784:3
50,000 shares@ US$1.173.4% of flowCommon StockSEC:0001209191-23-046784:4
Canonical exit: 16 Nov 2023 (T+90)
22,899 shares@ US$1.171.6% of flowCommon StockSEC:0001209191-23-046784:5
229,000 shares@ US$1.1841.2% of flowCommon StockSEC:0001209191-23-046784:0
Canonical exit: 15 Nov 2023 (T+90)
5,297 shares@ US$1.233.3% of flowCommon StockSEC:0001437749-23-023935:0
17,247 shares@ US$1.4359.6% of flowCommon Stock, $0.10 par valueSEC:0000921895-23-001700:0
8,796 shares@ US$1.43513.3% of flowCommon StockSEC:0001437749-23-020103:0
5,297 shares@ US$1.4353.7% of flowCommon StockSEC:0001437749-23-020159:0
9,407 shares@ US$1.43513.2% of flowCommon StockSEC:0001437749-23-020111:0
25 of 554 declarations
About Safeguard Scientifics Inc
Safeguard Scientifics Inc. (SFES) is a U.S.-based investment and value-creation company with a long history of supporting growth-stage and technology-oriented businesses. Founded in 1953 and incorporated in Pennsylvania, the company is headquartered in Radnor, Pennsylvania, United States. For many years, Safeguard was known for a venture/growth-capital model combined with hands-on operational support, helping entrepreneurs finance, build, and scale emerging businesses. From a market perspective, the company was previously listed on Nasdaq, but it was delisted in February 2024 and now trades on the OTCQX market under the symbol SFES. For investors in France, Belgium, and Switzerland, that means this is a U.S. micro-cap / illiquid situation whose equity story is more about portfolio value and capital allocation than about a conventional operating business.
Safeguard’s core business is the ownership of stakes in private and growth-oriented companies, with a philosophy centered on strategic, financial, and operational support. Rather than selling a standard product line, the company acts as an active shareholder in its portfolio companies. Historically, Safeguard has focused on technology-driven sectors, especially digital health, financial services technology, and digital media. Its recent disclosures indicate exposure to healthcare data platforms, precision medicine, and business technology services. That positioning gives the company indirect exposure to long-duration secular themes, but it also makes results highly dependent on private-company valuations, funding needs, and execution risk at the portfolio level.
Read moreShow less
Geographically, Safeguard remains primarily a United States story, with its corporate base in Pennsylvania and investments that may span domestic and international markets depending on the underlying portfolio company. Competitively, it is a specialized, relatively small-scale investor operating in a crowded landscape that includes venture capital funds, private equity firms, and public-market investors. Its edge is not scale; it is sector familiarity, close board-level involvement, and the ability to support innovative companies through their commercialization and growth phases.
The most important recent development is the company’s exit from Nasdaq and move to OTCQX in February 2024, followed by the filing of Form 15 with the SEC. That step materially changed the company’s public-market profile and reduced ongoing SEC reporting obligations. In the context of insider transaction analysis, Safeguard should therefore be viewed as a U.S. investment holding company with a legacy technology/growth-capital franchise, rather than as a traditional industrial or software issuer.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
